Reanalysis of the HIV-1 circulating recombinant form A/E (CRF01-AE): Evidence of A/E/G recombination

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 1, 2002, Pages 124-129

  Magiorkinis, Gkikas ^a   Paraskevis, Dimitris ^a   Magiorkinis, Emmanouil ^a   Vandamme, Anne Mieke ^a   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

HIV 1; Phylogenetic analysis; Recombination; Subtype E

Indexed keywords

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOSAICISM; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS TYPING;

EID: 0036570960     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200205010-00017     Document Type: Article

References (35)

1. HIV vaccine development: A progress report
2. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: Generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization
3. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro
4. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization subtypes but partially correspond to antigenic serotypes
5. HIV-1 nomenclature proposal
6. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand
7. An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)
8. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I
9. Molecular analysis of the full-length genome of HIV type 1 subtype I: Evidence of A/G/I recombination
10. Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): Unidentified regions may be derived from parental subtype E sequences
11. Reanalysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I,' reveals a unique complex A/G/H/K/? mosaic pattern
12. The molecular epidemiology of HIV-1 among male sex workers in Northern Thailand
13. HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996
14. HIV type 1 env gene diversity detected in Taiwan
15. HIV type 1 subtypes in Guangxi province, China, 1996
16. Molecular phylogenetic analysis of human immunodeficiency virus type 1 strains obtained from Korean patients: Env gene sequences
17. Analysis of sequence diversity in the C2-V3 regions of the external glycoproteins of HIV type 1 in Singapore
18. The molecular epidemiology of HIV in Asia
19. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin
20. At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England
21. Multiple introductions of HIV-1 subtype E into the Western Hemisphere
22. CLUSTAL V: Improved software for multiple sequence alignment
23. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice
24. Simplot
25. The neighbor-joining method: A new method for reconstructing phylogenetic trees
26. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequence
27. Risk factors for HIV infection among young adult men in Northern Thailand
28. Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E
29. Identification of a complex env subtype E HIV type 1 virus from the democratic republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes
30. HIV vaccine development: A subtype Especific strategy
31. AIDSVAX (MN) in Bangkok injecting drug users: A report on safety and immunogenicity, including macrophage-tropic virus neutralization
32. The WHO and why of HIV vaccine trials
33. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine